| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016PLoSO..1150672K |
| P356 | DOI | 10.1371/JOURNAL.PONE.0150672 |
| P932 | PMC publication ID | 4780771 |
| P698 | PubMed publication ID | 26950848 |
| P5875 | ResearchGate publication ID | 297594127 |
| P50 | author | Lars Lannfelt | Q5935335 |
| Payam Emami Khoonsari | Q57021586 | ||
| Martin Ingelsson | Q87848339 | ||
| Jonas Bergquist | Q40312473 | ||
| Peter Nilsson | Q45896164 | ||
| P2093 | author name string | Kim Kultima | |
| Lena Kilander | |||
| Anna Häggmark | |||
| Maria Mikus | |||
| Maria Lönnberg | |||
| Ganna Shevchenko | |||
| P2860 | cites work | OpenMS - an open-source software framework for mass spectrometry | Q21284208 |
| Quantitative proteomic analysis of human substantia nigra in Alzheimer's disease, Huntington's disease and Multiple sclerosis | Q24297593 | ||
| Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum | Q24300009 | ||
| Global prevalence of dementia: a Delphi consensus study | Q24603249 | ||
| Tyrosine kinase signalling in breast cancer: modulation of tyrosine kinase signalling in human breast cancer through altered expression of signalling intermediates | Q24803027 | ||
| Depletion of highly abundant proteins from human cerebrospinal fluid: a cautionary note | Q26782645 | ||
| Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkers | Q27008249 | ||
| Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
| Fibulins: a versatile family of extracellular matrix proteins | Q28207887 | ||
| PEAKS: powerful software for peptide de novo sequencing by tandem mass spectrometry | Q28209613 | ||
| The leucine-rich repeat as a protein recognition motif | Q28212461 | ||
| The classical complement cascade mediates CNS synapse elimination | Q28261273 | ||
| Open mass spectrometry search algorithm | Q28286936 | ||
| Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers | Q28477629 | ||
| Open source libraries and frameworks for mass spectrometry based proteomics: a developer's perspective | Q28660368 | ||
| MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification | Q29547200 | ||
| TANDEM: matching proteins with tandem mass spectra | Q29615238 | ||
| Andromeda: a peptide search engine integrated into the MaxQuant environment | Q29615816 | ||
| Alzheimer's disease | Q29616743 | ||
| Microarray data normalization and transformation | Q29617789 | ||
| Computational methods for protein identification from mass spectrometry data | Q30000994 | ||
| PEAKS DB: De Novo Sequencing Assisted Database Search for Sensitive and Accurate Peptide Identification | Q30053602 | ||
| Comparison of Mascot and X!Tandem performance for low and high accuracy mass spectrometry and the development of an adjusted Mascot threshold | Q30486531 | ||
| An automated method for baseline correction, peak finding and peak grouping in chromatographic data | Q30624517 | ||
| Comparative evaluation of preprocessing freeware on chromatography/mass spectrometry data for signature discovery | Q30838710 | ||
| Evaluation of algorithms for protein identification from sequence databases using mass spectrometry data | Q30909732 | ||
| A comparative evaluation of software for the analysis of liquid chromatography-tandem mass spectrometry data from isotope coded affinity tag experiments | Q30991942 | ||
| Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. | Q33254291 | ||
| Normalization of oligonucleotide arrays based on the least-variant set of genes | Q33322408 | ||
| A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. | Q33731693 | ||
| Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation | Q33810171 | ||
| Regulation of signaling by protein-tyrosine phosphatases: potential roles in the nervous system | Q33844146 | ||
| Cerebrospinal fluid and plasma biomarkers in Alzheimer disease | Q34098866 | ||
| Tyrosine kinases and gastric cancer | Q34103663 | ||
| Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients | Q34173955 | ||
| Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment | Q34220290 | ||
| Protein markers for the differential diagnosis of vascular dementia and Alzheimer's disease | Q34305901 | ||
| An automated pipeline for high-throughput label-free quantitative proteomics | Q34326747 | ||
| Longitudinal characterization of the brain proteomes for the tg2576 amyloid mouse model using shotgun based mass spectrometry. | Q34438884 | ||
| Alzheimer's disease and the aging brain | Q34552927 | ||
| Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment | Q34630522 | ||
| Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. | Q50483624 | ||
| Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease. | Q50489370 | ||
| Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients. | Q51817898 | ||
| SPIDER: software for protein identification from sequence tags with de novo sequencing error. | Q51966249 | ||
| Probabilistic Consensus Scoring Improves Tandem Mass Spectrometry Peptide Identification | Q57011814 | ||
| Receptor tyrosine phosphatases in axon growth and guidance | Q74102347 | ||
| Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity | Q85169334 | ||
| Quantification of the brain proteome in Alzheimer's disease using multiplexed mass spectrometry | Q35113785 | ||
| Gastric cancer: prognostic and diagnostic advances | Q35677119 | ||
| Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease. | Q35917235 | ||
| Protein tyrosine phosphatases and signalling | Q36092317 | ||
| The receptor protein tyrosine phosphatase (RPTP)beta/zeta is expressed in different subtypes of human breast cancer | Q36156124 | ||
| Current challenges in software solutions for mass spectrometry-based quantitative proteomics | Q36162392 | ||
| Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains | Q36243522 | ||
| Utilities for quantifying separation in PCA/PLS-DA scores plots | Q36501475 | ||
| LRG-accelerated differentiation defines unique G-CSFR signaling pathways downstream of PU.1 and C/EBPepsilon that modulate neutrophil activation | Q36648032 | ||
| Decrease of fibulin-3 in hepatocellular carcinoma indicates poor prognosis | Q37064102 | ||
| Comparative LC-MS: a landscape of peaks and valleys | Q37093728 | ||
| Combining results of multiple search engines in proteomics | Q37160902 | ||
| Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases | Q37206262 | ||
| Analysis of SNARE complex/synaptotagmin-1 interactions by one-dimensional NMR spectroscopy | Q37265752 | ||
| Development and evaluation of normalization methods for label-free relative quantification of endogenous peptides. | Q37379620 | ||
| Fibulins: multiple roles in matrix structures and tissue functions. | Q37384312 | ||
| Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. | Q37493113 | ||
| Immune proteins in brain development and synaptic plasticity. | Q37617631 | ||
| Role of fibulin-3 in lung cancer: in vivo and in vitro analyses | Q39076211 | ||
| Intralipid decreases apolipoprotein M levels and insulin sensitivity in rats | Q39141955 | ||
| A case study on the comparison of different software tools for automated quantification of peptides | Q39538264 | ||
| Multidimensional plasma protein separation technique for identification of potential Alzheimer's disease plasma biomarkers: a pilot study | Q39641295 | ||
| Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases | Q39860782 | ||
| Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease | Q40190874 | ||
| Protein tyrosine phosphatases in the developing nervous system | Q41750944 | ||
| Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease | Q45172855 | ||
| Antibody-based profiling of cerebrospinal fluid within multiple sclerosis | Q45896107 | ||
| Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects. | Q46003867 | ||
| Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease | Q48172055 | ||
| Use of within-array replicate spots for assessing differential expression in microarray experiments | Q48502901 | ||
| Age-related changes in cerebrospinal fluid protein concentrations | Q48702077 | ||
| The macroeconomics of dementia--will the world economy get Alzheimer's disease? | Q50119626 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cerebrospinal fluid | Q54196 |
| Alzheimer's disease | Q11081 | ||
| P304 | page(s) | e0150672 | |
| P577 | publication date | 2016-03-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease | |
| P478 | volume | 11 |
| Q90028613 | A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection |
| Q42684122 | A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease |
| Q92995041 | Abundant neuroprotective chaperone Lipocalin-type prostaglandin D synthase (L-PGDS) disassembles the Amyloid-β fibrils |
| Q42281478 | Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes. |
| Q91763319 | Amyloid β chaperone - lipocalin-type prostaglandin D synthase acts as a peroxidase in the presence of heme |
| Q39178864 | CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma |
| Q36357894 | Changes of Cerebrospinal Fluid Peptides due to Tauopathy. |
| Q89576000 | Discovery of the Consistently Well-Performed Analysis Chain for SWATH-MS Based Pharmacoproteomic Quantification |
| Q57469898 | Exome sequencing in an Italian family with Alzheimer's disease points to a role for seizure-related gene 6 (SEZ6) rare variant R615H |
| Q97535190 | Extracellular proteostasis prevents aggregation during pathogenic attack |
| Q37329676 | Functions of the Alzheimer's Disease Protease BACE1 at the Synapse in the Central Nervous System. |
| Q91583660 | Lipid-Binding Proteins in Brain Health and Disease |
| Q47417067 | Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults |
| Q58779295 | Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias |
| Q47763379 | Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications |
| Q47932570 | Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update |
| Q56983020 | Proteomics of neurodegenerative diseases: analysis of human post-mortem brain |
| Q98613084 | Six-Gene Signature Associated with Immune Cells in the Progression of Atherosclerosis Discovered by Comprehensive Bioinformatics Analyses |
| Q90564396 | The Challenge to Search for New Nervous System Disease Biomarker Candidates: the Opportunity to Use the Proteogenomics Approach |
| Q39167734 | The potential impact of recent insights into proteomic changes associated with glaucoma |
Search more.